Raj Enterprises of Central Florida LLC

Raj Enterprises of Central Florida LLC was paid $74K by Medicaid between Jan 2018 and May 2018, across 30 billing codes. Its largest line is G0483, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed — 65% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Florida

Rank by total paid#113 of 225

Median peer was paid$74K

This provider vs. median1.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	13,278	$74K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	65%	721	512	$48K
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	21%	634	544	$15K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	7.8%	556	475	$6K
80369		<1%	670	306	$359.43
80373		<1%	342	306	$299.28
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	516	443	$289.19
80366		<1%	297	269	$280.98
80324		<1%	1,470	301	$239.74
80355		<1%	296	269	$237.15
80335		<1%	1,156	219	$216.00
80346		<1%	344	303	$205.35
80356		<1%	343	306	$188.70

18 more codes

80362		<1%	806	$158.10
80361		<1%	346	$157.10
80358		<1%	669	$137.88
83992		<1%	278	$130.62
80371		<1%	248	$123.75
80367		<1%	269	$112.83
80372		<1%	276	$112.83
80351		<1%	237	$108.90
80332		<1%	245	$106.90
80349		<1%	245	$94.05
80323		<1%	240	$94.05
80365		<1%	336	$92.21
80353		<1%	341	$87.09
80342		<1%	240	$84.27
80354		<1%	338	$81.60
80360		<1%	306	$79.20
80345		<1%	472	$77.43
80321		<1%	41	$60.80

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPORTER, JAMES (OWNER)

Same official

Other billing entities under PORTER, JAMES

Full network →

Provider	Location	Paid
James W. Porter II, DMD, LLC	Albertville, AL	$73K
Suttons Bay-Bingham Fire & Rescue Authority	Suttons Bay, MI	$3K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.